PUNE, India, October 6, 2015 /PRNewswire/ --
Sandlerresearch.org adds "Global Neuroprosthetics Market 2015-2019 - Industry research report" that forecasts the worldwide neuroprosthetics industry to grow at a CAGR of 7.08% over the period 2014-2019.
Complete report on neuroprosthetics market spread across 78 pages, analyzing 6 major companies and supported with 36 data exhibits is now available at http://www.sandlerresearch.org/global-neuroprosthetics-market-2015-2019-industry-research-report.html.
This 2015 research on neuroprosthetics market is segmented based on Applications (Cognitive devices [cochlear implants], Neuromodulation devices), Technology (SCS, DBS, SNS, VNS system and Others) and by Region (Americas, APAC, and EMEA). The report covers landscape of the global neuroprosthetics market and its growth prospects in the coming years. These devices either are implanted inside the body or can be worn externally. These are used either to replace a lost function of the body such as cognitive ability or to treat neurological conditions such as depression, chronic pain, epilepsy, or spinal cord injuries.
The following companies are the key players in the Global Neuroprosthetics Market: Boston Scientific, Medtronic, St. Jude Medical, Cochlear Ltd. and Sonova Holding. Other Prominent Vendors in the market are: Aleva Neuroprosthetics, Atrotech, Autonomic Technologies, BrainGate, electroCore, Mainstay Medical, Med-EL, NeuroPace, Nevro, Soterix Medical, and Oticon Medical. Order a copy of Global Neuroprosthetics Market 2015-2019 - Industry research report research report at http://www.sandlerresearch.org/purchase?rname=44192.
Commenting on this global neuroprosthetics market report, an analyst said: "Most neuroprosthetics manufacturers are US-based companies. These companies acquire overseas device manufacturers to expand their businesses and for tax exemptions. For instance, Medtronic acquired Covidien in January 2015 to reduce the cost of taxes generated on the former's revenue. Pfizer is expected to acquire UK-based AstraZeneca in part to gain entry into the UK. This deal can help Pfizer reduce its taxes by $1 billion annually."
According to the Global Neuroprosthetics Market 2015-2019 - Industry research report, individuals with chronic pain, epilepsy, Parkinson's disease, and depression prefer first-line treatment options such as meditation, physiotherapy, and drugs. However, people with these diseases may develop resistance to drugs, resulting in the ineffectiveness of first-line treatment options. In these cases, people opt for neuroprosthetic devices as a second-line treatment option. These devices have many advantages over first-line treatment options.
Further, the report states that the high cost of neuroprosthetics coupled with reimbursement restrictions impedes the accessibility of these devices. Key market drivers like increased prevalence of neurological disorders, Availability of funds for R&D, Numerous product approvals and Second-line treatment are discussed in this research. Market challenges faced by players and end-users include battery lifetime, limited compatibility with MRI, X-ray, and ultrasound equipment, limited reimbursement scenario, GPOs as intermediary, stringent regulations and cost containment. Market trends of overseas expansions, hybrid neuroprosthetic devices, next-generation therapies for CNS disorders, aesthetically appealing prosthetics and use in US military are also discussed in this neuroprosthetic market research.
Complete list of data exhibits, comprehensive table of contents and more on this neuroprosthetics market report is available at http://www.sandlerresearch.org/toc/global-neuroprosthetics-market-2015-2019-industry-research-report.html.
On a related note, another regional research titled Cochlear Implants Market in the US 2015-2019 forecasts a 15.21% CAGR growth for cochlear implants market in the US. This report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the Cochlear Implants market in the US and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Cochlear, MED-EL, Sonova Holding and William Demant Holding are the companies discussed in this research available at http://www.sandlerresearch.org/cochlear-implants-market-in-the-us-2015-2019.html .
Explore more reports related to Medical Device industry at: http://www.sandlerresearch.org/market-research/medical-device
SandlerResearch.org offers in-depth studies and research reports on a range of micro markets. Not limited to any one industry, SandlerResearch.org offers research studies on agriculture, energy and power, chemicals, environment, pharmaceuticals, biotechnology, water, advanced materials and much more.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
+ 1 888 391 5441
Connect With Us on:
G+ / Google Plus: https://plus.google.com/+SandlerresearchOrg/posts
SOURCE Sandler Research